3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and Nerve Degeneration

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chugh, A; Johnson, RL; Marcotte, ER; Mishra, RK	1

Other Studies

1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and Nerve Degeneration

Article	Year
Protection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1) Peptides, 1998, Volume: 19, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; MSH Release-Inhibiting Hormone; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Parkinson Disease, Secondary; Pyrrolidinones; Receptors, Dopamine	1998

Article

Year

Protection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)

Peptides, 1998, Volume: 19, Issue:2

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; MSH Release-Inhibiting Hormone; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Parkinson Disease, Secondary; Pyrrolidinones; Receptors, Dopamine

1998